Reshape Lifesciences Stock Price on July 19, 2023
| RSLS Stock | USD 5.73 0.10 1.78% |
Below is the normalized historical share price chart for ReShape Lifesciences extending back to October 06, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of ReShape Lifesciences stands at 5.73, as last reported on the 30th of November, with the highest price reaching 5.73 and the lowest price hitting 5.73 during the day.
If you're considering investing in ReShape Stock, it is important to understand the factors that can impact its price. ReShape Lifesciences maintains Sharpe Ratio (i.e., Efficiency) of -0.0603, which implies the firm had a -0.0603% return per unit of standard deviation over the last 3 months. ReShape Lifesciences exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check ReShape Lifesciences' Market Risk Adjusted Performance of 3.67, risk adjusted performance of (0.05), and Coefficient Of Variation of (1,369) to confirm the risk estimate we provide.
Common Stock Shares Outstanding is likely to gain to about 128.9 K in 2024, whereas Total Stockholder Equity is likely to drop slightly above 6.3 M in 2024. . Price To Sales Ratio is likely to drop to 0.16 in 2024. Price Earnings Ratio is likely to drop to -0.14 in 2024. ReShape Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 15th of November 2007 | 200 Day MA 9.5288 | 50 Day MA 6.1109 | Beta 1.346 |
ReShape |
Sharpe Ratio = -0.0603
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | RSLS |
Estimated Market Risk
| 6.92 actual daily | 61 61% of assets are less volatile |
Expected Return
| -0.42 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average ReShape Lifesciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ReShape Lifesciences by adding ReShape Lifesciences to a well-diversified portfolio.
Price Book 2.7558 | Enterprise Value Ebitda (0.02) | Price Sales 0.5261 | Shares Float 466.6 K | Wall Street Target Price 1 |
ReShape Lifesciences Main Headline on 19th of July 2023
Sale by Thomas Stankovich of 106 shares of ReShape Lifescien... by Thomas Stankovich
Filed transaction by Reshape Lifesciences Inc officer. General open market or private sale of non-derivative or derivative security
ReShape Lifesciences Valuation on July 19, 2023
It is possible to determine the worth of ReShape Lifesciences on a given historical date. On July 19, 2023 ReShape was worth 81.2 at the beginning of the trading date compared to the closed value of 82.94. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of ReShape Lifesciences stock. Still, in general, we apply an absolute valuation method to find ReShape Lifesciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of ReShape Lifesciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against ReShape Lifesciences' related companies.
| Open | High | Low | Close | Volume | |
| 87.00 | 90.48 | 81.78 | 81.80 | 60,106 | |
07/19/2023 | 81.20 | 86.99 | 81.20 | 82.94 | 33,866 |
| 83.52 | 85.84 | 81.78 | 83.52 | 28,274 |
| Backtest ReShape Lifesciences | | | ReShape Lifesciences History | | | ReShape Lifesciences Valuation | Previous | Next |
ReShape Lifesciences Trading Date Momentum on July 19, 2023
| On July 20 2023 ReShape Lifesciences was traded for 83.52 at the closing time. The top price for the day was 85.84 and the lowest listed price was 81.78 . The trading volume for the day was 28.3 K. The trading history from July 20, 2023 was a factor to the next trading day price appreciation. The trading delta at closing time against the next closing price was 0.70% . The trading delta at closing time against the current closing price is 1.40% . |
ReShape Lifesciences Fundamentals Correlations and Trends
By evaluating ReShape Lifesciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among ReShape Lifesciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. ReShape financial account trend analysis is a perfect complement when working with valuation or volatility modules.About ReShape Lifesciences Stock history
ReShape Lifesciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ReShape is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ReShape Lifesciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ReShape Lifesciences stock prices may prove useful in developing a viable investing in ReShape Lifesciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 102.7 K | 128.9 K | |
| Net Loss | -41.6 M | -43.7 M |
ReShape Lifesciences Stock Technical Analysis
ReShape Lifesciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
ReShape Lifesciences Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
ReShape Lifesciences cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
ReShape Lifesciences November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how ReShape Lifesciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ReShape Lifesciences shares will generate the highest return on investment. By undertsting and applying ReShape Lifesciences stock market strength indicators, traders can identify ReShape Lifesciences entry and exit signals to maximize returns
ReShape Lifesciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for ReShape Lifesciences' price direction in advance. Along with the technical and fundamental analysis of ReShape Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of ReShape to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.49) | |||
| Total Risk Alpha | (1.65) | |||
| Treynor Ratio | 3.66 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for ReShape Stock Analysis
When running ReShape Lifesciences' price analysis, check to measure ReShape Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ReShape Lifesciences is operating at the current time. Most of ReShape Lifesciences' value examination focuses on studying past and present price action to predict the probability of ReShape Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ReShape Lifesciences' price. Additionally, you may evaluate how the addition of ReShape Lifesciences to your portfolios can decrease your overall portfolio volatility.